The GIRAFE phase II trial on MVCT-based 'volumes of the day' and 'dose of the day' addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer

Autor: Vincent Esteyrie, Baptiste Gleyzolle, Amélie Lusque, Pierre Graff, Anouchka Modesto, Michel Rives, Michel Lapeyre, Jacques Desrousseaux, Eliane Graulières, Gregory Hangard, François-Xavier Arnaud, Regis Ferrand, Jean-Pierre Delord, Muriel Poublanc, Muriel Mounier, Thomas Filleron, Anne Laprie

Publikováno v: Clinical and Translational Radiation Oncology, Vol 16, Iss , Pp 34-39 (2019)

During exclusive curative radiotherapy for head and neck tumors, the patient’s organs at risk (OAR) and target volumes frequently change size and shape, leading to a risk of higher toxicity and lower control than expected on planned dosimetry. Adap

Externí odkaz: https://doaj.org/article/853faf3f1722433493b31a0134b24f2e

Precision Postoperative Radiotherapy in Sinonasal Carcinomas after Endonasal Endoscopic Surgery

Autor: Pierre Yves Marcy, Francois Regis Ferrand, Ludovic de Gabory, Benjamin Verillaud, Florent Carsuzaa, Juliette Thariat

Publikováno v: Contemporary Southeast Asia
Contemporary Southeast Asia, Taylor & Francis, 2021, 13 (19), pp.4802. ⟨10.3390/cancers13194802⟩
Cancers
Cancers, Vol 13, Iss 4802, p 4802 (2021)

Simple Summary Sinonasal cancers are rare and heterogeneous tumors, mainly carcinomas, with essentially local evolution and a severe vital and functional prognosis. These tumors are more and more being treated in first intent by a mini-morbid endosco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfd4c6c7545232008e8c48dc4b5c00b1
https://hal.archives-ouvertes.fr/hal-03412496

[OA236] Patient-specific quality assurance based on electronic portal imaging devices via artificial neural networks

Autor: Chatrie, Frédéric, Fouad, Younan, Jocelyne, Mazurier, Luc, Simon, Laure, Vieillevigne, Régis, Ferrand, Rita, Barbeiro Ana, Xavier, Franceries, Marie-Véronique, Le Lann

Publikováno v: In Physica Medica August 2018 52 Supplement 1:88-89

[Results of proton beam irradiation for treatment of choroidal melanoma]

Autor: Lumbroso L, Levy C, Plancher C, Frau E, D'hermies F, Schlienger P, Dendale R, Mammar H, Delacroix S, Nauraye C, Noel G, REGIS FERRAND, Desblancs C, Mazal A, Validire P, Asselain B, Desjardins L

Publikováno v: Europe PubMed Central

To evaluate the results of proton beam irradiation of choroidal melanomas on a large series of patients.Retrospective analysis of a series of patients treated with proton beam irradiation between 1991 and December 1998. The data were analyzed to eval

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e1d0daa24293a3ac703bc2062b3c6b23
https://pubmed.ncbi.nlm.nih.gov/11941255

[Optic neuropathy after proton-beam therapy for malignant choroidal melanoma]

Autor: Meyer A, Lévy C, Blondel J, D'hermies F, Frau E, Schlienger P, Mammar H, Delacroix S, Nauraye C, Desblancs C, REGIS FERRAND, Mazal A, Asselain B, Plancher C, Habrand J, Desjardins L

Publikováno v: Europe PubMed Central

Proton-beam irradiation is a conservative therapy commonly used for the treatment of uveal malignant melanomas. Some adverse effects such as optic neuropathy can compromise the visual outcome. We were interested in determining the risk factors for ra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::bf2b98cf3571b54c4d94daa0b743cbf9
https://pubmed.ncbi.nlm.nih.gov/10880919